To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.
119th Congress
Bill Overview
HR7953 is active in the 119th Congress. Latest action: Referred to the House Committee on Energy and Commerce. (3/17/2026).
Legislative Activity
In House Committee
Latest action: Referred to the House Committee on Energy and Commerce. (3/17/2026)
Full Bill Text
We're fetching the official bill text from Congress.gov. Check back shortly.